Through its Cerenovus brand, Johnson & Johnson MedTech is dedicated to changing the trajectory of stroke care. With a comprehensive portfolio for the treatment of ischemic and hemorrhagic stroke, Cerenovus provides innovative, evidence-based technologies designed to improve outcomes and save lives.